MS Latest Research Update from New Zealand Multiple Sclerosis Research
Keep up to date on the latest MS and COVID-19 data
Microsoft Chases General AI with New Research Group
MSAA Publications
Comprehensive MS Research Update Now Available from MSAA
COMMENTS
What's New in MS Research
This edition of "What's New in MS Research" The astounding breadth of research being conducting into the causes, manifestations, and management of multiple sclerosis (MS) was on full display when thousands of physicians, nurses, laboratory scientists, and others gathered in Denver in April for the annual meeting of the American Academy of Neurology (AAN).
CAR-T therapy for multiple sclerosis enters US trials for first time
Multiple sclerosis (MS) is an autoimmune disease, driven by misguided T and B cells that attack nerve cells. ... Medical research; Diseases; Latest on: Immunology. A disease-associated gene desert ...
Could What Makes Multiple Sclerosis Worse Lead to a Cure?
A study of over 22,000 people with multiple sclerosis reveals a genetic variant that increases the risk of disability and accelerates the disease progression. The variant is linked to genes involved in repairing damaged cells and controlling viral infections in the nervous system.
Research News and Progress for MS
2021 - Society-funded researchers discover brain cells that fight inflammation with instructions from gut bacteria. 2022 - Pathways to MS Cures research roadmap published and gains global endorsement. 2022 - Society-funded researchers publish the strongest evidence yet that Epstein-Barr virus can trigger MS when other risk factors are present.
MS Cure: Latest Research and Clinical Trials
Learn about the new treatments, FDA approvals, and experimental therapies for multiple sclerosis (MS), a chronic autoimmune disease. Find out how researchers are exploring the causes, risk factors, and genetics of MS.
Research Forum Brief
Research advances are driving real-world impact faster than ever, with the latest advances in AI transforming the way we all live, work, and think. In this episode, researchers dive into the importance of globally inclusive and equitable AI, share updates on AutoGen and MatterGen, explore novel use cases for AI, and more. ...
Multiple Sclerosis Research News -- ScienceDaily
Information on multiple sclerosis. Read current research articles and learn about multiple sclerosis diagnosis, symptoms as well as the latest MS treatment options.
A neural stem-cell treatment for progressive multiple sclerosis
A phase 1 trial using an allogeneic stem-cell-based therapy in people with progressive multiple sclerosis (MS) shows the feasibility and tolerability of the approach; rigorous evaluation of this ...
Multiple sclerosis
Multiple sclerosis is an autoimmune disease in which immune cells attack and destroy the protective myelin sheaths that surround nerve fibres, leading to neurological disturbances. Latest Research ...
FDA OKs Phase 2 clinical trial of KYV-101 for progressive MS
The U.S. Food and Drug Administration (FDA) has cleared a Phase 2 clinical trial to test Kyverna Therapeutics ' cell-based therapy candidate KYV-101 in people with treatment-resistant ...
Pathways to cures for multiple sclerosis: A research roadmap
In this report, we share the Society's Pathways to MS Cures Research Roadmap. The Roadmap was developed with input from scientific experts, health care providers, and people affected by MS from the United States, Canada, and the United Kingdom ().The Roadmap has also been endorsed by leading MS patient and professional organizations ().We hope the Roadmap will inspire greater collaboration ...
Scientists crack mystery of how MS gene spread
'Major moment in MS research' as new trial starts. Published. 4 April 2023 'I was put into care home for elderly at 46' Published. 27 November 2019. Do we finally know the cause of multiple sclerosis?
'Major moment in MS research' as new Octopus trial starts
The Octopus trial - so-called because it is a multi-arm, multi-stage trial - is being run by Prof Jeremy Chataway, from the National Hospital for Neurology and Neurosurgery UCLH in London, with £ ...
Latest MS Research and News
Phase 3 trials show evobrutinib is no better than existing treatments for people with relapsing MS. Pharmaceutical company Merck announced the results of the EVOLUTION (evolutionRMS1 and evolutionRMS2) clinical trials earlier this month. They found evobrutinib wasn't more effective at reducing relapses than existing drug teriflunomide.
A New Approach to M.S. Could Transform Treatment of Other Diseases
Saud Sadiq is the director and chief research scientist of the Tisch Multiple Sclerosis Research Center of New York and the head of the adjacent clinical practice. Speaking with his patients can ...
Multiple sclerosis: New biomarker confirmed for early diagnosis
Multiple sclerosis: New biomarker confirmed for early diagnosis. ScienceDaily . Retrieved June 1, 2024 from www.sciencedaily.com / releases / 2023 / 07 / 230706124618.htm
Multiple sclerosis: The most recent research on treatments
Another study, MS-STAT2, is looking at whether simvastatin, a drug commonly used to treat high cholesterol, could also be used to slow secondary progressive MS. This phase 3 trial completed its ...
Multiple Sclerosis News -- ScienceDaily
Sep. 25, 2023 — New research is painting a clearer picture of the early signs of multiple sclerosis (MS), showing that people are nearly twice as likely to experience mental illness in the years ...
Research We Fund and Support
In 1946 the National MS Society sponsored its first three research projects. Today our investment in innovative research exceeds $1 billion, and with this investment we've: Recruited and provided training to more than 1,000 new MS researchers to the field. Provided early career support and funding to many thought leaders in MS research.
Most stem cells die after being injected into the brain. This new
Research team uses shear-thinning hydrogels instead of saline solution; could lead to new therapies for MS, other neurological diseases . By Laurie Kaiser. Release Date: June 5, 2024 . ... Multiple sclerosis (MS) is the most common demyelinating disease, affecting more than 2.5 million individuals globally every year. ...
Multiple Sclerosis News & Updates
International Workshop Focuses on Aging with Multiple Sclerosis. Almost half of all people living with MS today are 55 years of age or older, and more people are getting diagnosed with MS at later ages than ever before. Research News, Lifestyle and Wellness, Restore What's Been Lost, Stop Disease Progression, Wellness Research View More.
Microsoft Research Forum
Microsoft Research Forum. Join us for a continuous exchange of ideas about science and technology research in the era of general AI. This series will explore recent research advances, bold new ideas, and important discussions with the global research community. Register to receive access to all episodes and be part of the conversation.
Microsoft On The Issues
Broadening AI innovation: Microsoft's pledge to the National AI Research Resource pilot Jan 18, 2024 | Colleen Kerr - Senior Director, Government Affairs. ... Microsoft announces new steps to help protect elections Nov 2, 2023 | Brad Smith - Vice Chair & President. A new world of security: Microsoft's Secure Future Initiative View More
Epstein-Barr Virus and brain cross-reactivity: possible mechanism for
Jan. 13, 2022 — A new study provides compelling evidence of causality between Epstein-Barr virus and multiple sclerosis. It suggests that most MS cases could be prevented by stopping EBV ...
Microsoft Research chief scientist has no issue with Recall
Thu 6 Jun 2024 // 07:26 UTC. Asked to explore the data privacy issues arising from Microsoft Recall, the Windows maker's poorly received self-surveillance tool, Jaime Teevan, chief scientist and technical fellow at Microsoft Research, brushed aside concerns. Teevan was speaking on Wednesday with Erik Brynjolfsson, director of the Stanford ...
IMAGES
COMMENTS
This edition of "What's New in MS Research" The astounding breadth of research being conducting into the causes, manifestations, and management of multiple sclerosis (MS) was on full display when thousands of physicians, nurses, laboratory scientists, and others gathered in Denver in April for the annual meeting of the American Academy of Neurology (AAN).
Multiple sclerosis (MS) is an autoimmune disease, driven by misguided T and B cells that attack nerve cells. ... Medical research; Diseases; Latest on: Immunology. A disease-associated gene desert ...
A study of over 22,000 people with multiple sclerosis reveals a genetic variant that increases the risk of disability and accelerates the disease progression. The variant is linked to genes involved in repairing damaged cells and controlling viral infections in the nervous system.
2021 - Society-funded researchers discover brain cells that fight inflammation with instructions from gut bacteria. 2022 - Pathways to MS Cures research roadmap published and gains global endorsement. 2022 - Society-funded researchers publish the strongest evidence yet that Epstein-Barr virus can trigger MS when other risk factors are present.
Learn about the new treatments, FDA approvals, and experimental therapies for multiple sclerosis (MS), a chronic autoimmune disease. Find out how researchers are exploring the causes, risk factors, and genetics of MS.
Research advances are driving real-world impact faster than ever, with the latest advances in AI transforming the way we all live, work, and think. In this episode, researchers dive into the importance of globally inclusive and equitable AI, share updates on AutoGen and MatterGen, explore novel use cases for AI, and more. ...
Information on multiple sclerosis. Read current research articles and learn about multiple sclerosis diagnosis, symptoms as well as the latest MS treatment options.
A phase 1 trial using an allogeneic stem-cell-based therapy in people with progressive multiple sclerosis (MS) shows the feasibility and tolerability of the approach; rigorous evaluation of this ...
Multiple sclerosis is an autoimmune disease in which immune cells attack and destroy the protective myelin sheaths that surround nerve fibres, leading to neurological disturbances. Latest Research ...
The U.S. Food and Drug Administration (FDA) has cleared a Phase 2 clinical trial to test Kyverna Therapeutics ' cell-based therapy candidate KYV-101 in people with treatment-resistant ...
In this report, we share the Society's Pathways to MS Cures Research Roadmap. The Roadmap was developed with input from scientific experts, health care providers, and people affected by MS from the United States, Canada, and the United Kingdom ().The Roadmap has also been endorsed by leading MS patient and professional organizations ().We hope the Roadmap will inspire greater collaboration ...
'Major moment in MS research' as new trial starts. Published. 4 April 2023 'I was put into care home for elderly at 46' Published. 27 November 2019. Do we finally know the cause of multiple sclerosis?
The Octopus trial - so-called because it is a multi-arm, multi-stage trial - is being run by Prof Jeremy Chataway, from the National Hospital for Neurology and Neurosurgery UCLH in London, with £ ...
Phase 3 trials show evobrutinib is no better than existing treatments for people with relapsing MS. Pharmaceutical company Merck announced the results of the EVOLUTION (evolutionRMS1 and evolutionRMS2) clinical trials earlier this month. They found evobrutinib wasn't more effective at reducing relapses than existing drug teriflunomide.
Saud Sadiq is the director and chief research scientist of the Tisch Multiple Sclerosis Research Center of New York and the head of the adjacent clinical practice. Speaking with his patients can ...
Multiple sclerosis: New biomarker confirmed for early diagnosis. ScienceDaily . Retrieved June 1, 2024 from www.sciencedaily.com / releases / 2023 / 07 / 230706124618.htm
Another study, MS-STAT2, is looking at whether simvastatin, a drug commonly used to treat high cholesterol, could also be used to slow secondary progressive MS. This phase 3 trial completed its ...
Sep. 25, 2023 — New research is painting a clearer picture of the early signs of multiple sclerosis (MS), showing that people are nearly twice as likely to experience mental illness in the years ...
In 1946 the National MS Society sponsored its first three research projects. Today our investment in innovative research exceeds $1 billion, and with this investment we've: Recruited and provided training to more than 1,000 new MS researchers to the field. Provided early career support and funding to many thought leaders in MS research.
Research team uses shear-thinning hydrogels instead of saline solution; could lead to new therapies for MS, other neurological diseases . By Laurie Kaiser. Release Date: June 5, 2024 . ... Multiple sclerosis (MS) is the most common demyelinating disease, affecting more than 2.5 million individuals globally every year. ...
International Workshop Focuses on Aging with Multiple Sclerosis. Almost half of all people living with MS today are 55 years of age or older, and more people are getting diagnosed with MS at later ages than ever before. Research News, Lifestyle and Wellness, Restore What's Been Lost, Stop Disease Progression, Wellness Research View More.
Microsoft Research Forum. Join us for a continuous exchange of ideas about science and technology research in the era of general AI. This series will explore recent research advances, bold new ideas, and important discussions with the global research community. Register to receive access to all episodes and be part of the conversation.
Broadening AI innovation: Microsoft's pledge to the National AI Research Resource pilot Jan 18, 2024 | Colleen Kerr - Senior Director, Government Affairs. ... Microsoft announces new steps to help protect elections Nov 2, 2023 | Brad Smith - Vice Chair & President. A new world of security: Microsoft's Secure Future Initiative View More
Jan. 13, 2022 — A new study provides compelling evidence of causality between Epstein-Barr virus and multiple sclerosis. It suggests that most MS cases could be prevented by stopping EBV ...
Thu 6 Jun 2024 // 07:26 UTC. Asked to explore the data privacy issues arising from Microsoft Recall, the Windows maker's poorly received self-surveillance tool, Jaime Teevan, chief scientist and technical fellow at Microsoft Research, brushed aside concerns. Teevan was speaking on Wednesday with Erik Brynjolfsson, director of the Stanford ...